Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TELA Bio, Inc.TELA · Entity 7381 | Chief Accounting Officer | February 18, 2026 | February 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TELA Bio, Inc.
Report date February 18, 2026 · Filed February 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 66,873 |
Ending reported balance
After 2026-02-23 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-02-18 · Grant · Acquired 32,850 · Balance 69,681 F1: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 18, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates. Row 2 · 2026-02-19 · Tax withholding · Disposed 795 · Balance 68,886 F2: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Row 3 · 2026-02-21 · Tax withholding · Disposed 1,590 · Balance 67,296 F2: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Row 4 · 2026-02-23 · Tax withholding · Disposed 423 · Balance 66,873 F2: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 18, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2026 Filed Feb 25, 2026 01:00 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 423 | $0.77 | $324.02 |
DisclosureSEC source: 0001899973-26-000002 · form4-02242026_080209.xml · nonDerivative · entry 4 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,873 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 21, 2026 Filed Feb 25, 2026 01:00 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 1,590 | $0.72 | $1,140.67 |
DisclosureSEC source: 0001899973-26-000002 · form4-02242026_080209.xml · nonDerivative · entry 3 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,296 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 19, 2026 Filed Feb 25, 2026 01:00 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 795 | $0.80 | $632.03 |
DisclosureSEC source: 0001899973-26-000002 · form4-02242026_080209.xml · nonDerivative · entry 2 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,886 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. Read SEC document |
| February 18, 2026 Filed Feb 25, 2026 01:00 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 32,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001899973-26-000002 · form4-02242026_080209.xml · nonDerivative · entry 1 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,681 F1 · shares: These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 18, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:46 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 96 | $1.22 | $117.12 |
DisclosureSEC source: 0001062993-25-006862 · form4.xml · nonDerivative · entry 1 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,831 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 21:57 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 539 | $2.65 | $1,428.35 |
DisclosureSEC source: 0001062993-25-003495 · form4.xml · nonDerivative · entry 3 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,927 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 23, 2025 Filed Feb 25, 2025 21:57 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 423 | $2.72 | $1,150.56 |
DisclosureSEC source: 0001062993-25-003495 · form4.xml · nonDerivative · entry 2 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,466 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 21:57 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 1,590 | $2.72 | $4,324.80 |
DisclosureSEC source: 0001062993-25-003495 · form4.xml · nonDerivative · entry 1 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,889 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 21:16 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 9,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003151 · form4.xml · nonDerivative · entry 1 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,479 F1 · shares: Includes 1,079 shares acquired under the Issuer's employee stock purchase plan on July 31, 2024. F2 · balance_after: These restricted stock units will vest in four equal annual installments beginning on February 19, 2026, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 23:43 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 96 | $5.67 | $544.32 |
DisclosureSEC source: 0001062993-24-007840 · form4.xml · nonDerivative · entry 1 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,000 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 24, 2024 Filed Feb 27, 2024 21:37 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 539 | $7.07 | $3,810.73 |
DisclosureSEC source: 0001062993-24-004584 · form4.xml · nonDerivative · entry 2 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,096 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:37 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 423 | $7.07 | $2,990.61 |
DisclosureSEC source: 0001062993-24-004584 · form4.xml · nonDerivative · entry 1 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,635 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:13 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 9,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004239 · form4.xml · nonDerivative · entry 2 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,058 F3 · shares: These restricted stock units will vest in four equal annual installments beginning on February 21, 2025, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:13 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 795 | $7.00 | $5,565.00 |
DisclosureSEC source: 0001062993-24-004239 · form4.xml · nonDerivative · entry 1 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,658 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. F2 · balance_after: Includes 1,022 shares acquired under the Company's employee stock purchase plan on January 31, 2024. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 22:03 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 96 | $10.64 | $1,021.44 |
DisclosureSEC source: 0001062993-23-008667 · form4.xml · nonDerivative · entry 1 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,431 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 00:14 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 539 | $11.03 | $5,945.17 |
DisclosureSEC source: 0001062993-23-005024 · form4.xml · nonDerivative · entry 2 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,527 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 00:14 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 423 | $10.50 | $4,441.50 |
DisclosureSEC source: 0001062993-23-005024 · form4.xml · nonDerivative · entry 1 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,066 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:10 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 9,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004533 · form4.xml · nonDerivative · entry 1 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,489 F1 · shares: These restricted stock units will vest in four equal annual installments beginning on February 21, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 20:45 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 93 | $11.63 | $1,081.59 |
DisclosureSEC source: 0001062993-22-009235 · form4.xml · nonDerivative · entry 1 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,089 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:25 UTC | TELA Bio, Inc. TELA · Entity 7381 | Tax withholdingCommon Stock | 535 | $11.98 | $6,409.30 |
DisclosureSEC source: 0001062993-22-005916 · form4.xml · nonDerivative · entry 1 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,182 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 22:09 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $11.75 | $0.00 |
DisclosureSEC source: 0001062993-22-005777 · form4.xml · derivative · entry 2 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2032-02-23 F2 · derivative.exercise_date: The option vests 25% on February 23, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 22:09 UTC | TELA Bio, Inc. TELA · Entity 7381 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-005777 · form4.xml · nonDerivative · entry 1 Smeykal Megan · CIK 0001899973 · Chief Accounting Officer · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,717 F1 · shares: These restricted stock units will vest in four equal annual installments beginning on February 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.